Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 29;129:275–379. doi: 10.1016/bs.apcsb.2021.11.007

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Elsevier Inc. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 5 — Visualization of the best interacting phytochemical with the identified targets. (A) ACE receptor with betulinic acid, (B) Cathepsin L receptor with 5″-(2⁗-Hydroxybenzyl)uvarinol, (C) Cathepsin B & K receptor with 5″-(2⁗-Hydroxybenzyl)uvarinol, (D) DPPR receptor with (−)-antofine, (E) EGFR receptor with S)-1′-methyloctyl caffeate, (F) HDAC2 with (Z)-3-phenyl-2-propenal, (G) IL6 with 7-oxo-10α-cucurbitadienol, (H) RIPK1 with PLX-4720, and (I) VEGFA with 5″-(2⁗-Hydroxybenzyl)uvarinol.